RU2004100228A - Замещенный арилазоимидазол для лечения недержания мочи при напряжении - Google Patents

Замещенный арилазоимидазол для лечения недержания мочи при напряжении Download PDF

Info

Publication number
RU2004100228A
RU2004100228A RU2004100228/15A RU2004100228A RU2004100228A RU 2004100228 A RU2004100228 A RU 2004100228A RU 2004100228/15 A RU2004100228/15 A RU 2004100228/15A RU 2004100228 A RU2004100228 A RU 2004100228A RU 2004100228 A RU2004100228 A RU 2004100228A
Authority
RU
Russia
Prior art keywords
substituted
treatment
arilazoimidazole
voltage
urine incontinence
Prior art date
Application number
RU2004100228/15A
Other languages
English (en)
Russian (ru)
Inventor
Роберт Уилль м ГРИСТВУД (GB)
Роберт Уилльям ГРИСТВУД
Дэвид КАВАЛЛА (GB)
Дэвид КАВАЛЛА
Original Assignee
Арачнова Терапьютикс Лтд. Сша Сосей Ко Лтд. (Jp)
Арачнова Терапьютикс Лтд. Сша Сосей Ко Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арачнова Терапьютикс Лтд. Сша Сосей Ко Лтд. (Jp), Арачнова Терапьютикс Лтд. Сша Сосей Ко Лтд. filed Critical Арачнова Терапьютикс Лтд. Сша Сосей Ко Лтд. (Jp)
Publication of RU2004100228A publication Critical patent/RU2004100228A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2004100228/15A 2001-06-08 2002-06-07 Замещенный арилазоимидазол для лечения недержания мочи при напряжении RU2004100228A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0114008.6A GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use
GB0114008.6 2001-06-08

Publications (1)

Publication Number Publication Date
RU2004100228A true RU2004100228A (ru) 2005-06-10

Family

ID=9916211

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004100228/15A RU2004100228A (ru) 2001-06-08 2002-06-07 Замещенный арилазоимидазол для лечения недержания мочи при напряжении

Country Status (13)

Country Link
US (1) US20040242547A1 (enExample)
EP (1) EP1399167A1 (enExample)
JP (1) JP2005500285A (enExample)
KR (1) KR20040030654A (enExample)
CN (1) CN1234367C (enExample)
AU (1) AU2002311445B2 (enExample)
BR (1) BR0210195A (enExample)
CA (1) CA2449957A1 (enExample)
GB (1) GB0114008D0 (enExample)
MX (1) MXPA03011226A (enExample)
RU (1) RU2004100228A (enExample)
WO (1) WO2002100414A1 (enExample)
ZA (1) ZA200309473B (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056123B2 (ja) * 1979-07-30 1985-12-09 持田製薬株式会社 浮腫・低血圧・心不全および粘膜充血治療用剤
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US6323231B1 (en) * 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence

Also Published As

Publication number Publication date
CN1234367C (zh) 2006-01-04
JP2005500285A (ja) 2005-01-06
ZA200309473B (en) 2005-03-23
EP1399167A1 (en) 2004-03-24
AU2002311445B2 (en) 2005-08-25
CA2449957A1 (en) 2002-12-19
WO2002100414A1 (en) 2002-12-19
CN1541099A (zh) 2004-10-27
GB0114008D0 (en) 2001-08-01
US20040242547A1 (en) 2004-12-02
BR0210195A (pt) 2004-07-27
MXPA03011226A (es) 2004-03-26
KR20040030654A (ko) 2004-04-09

Similar Documents

Publication Publication Date Title
ATE471148T1 (de) Medizinische verwendung eines tetrahydrotriazoloä4,3-aüpyrazins
PT1177176E (pt) Derivados de acidos triarilicos como ligandos de receptores ppar.
DE60204722D1 (de) Quinazolinderivate für die behandlung durch t-zellen vermittelter krankheiten
DE60141855D1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
EP2298237A3 (en) Papilloplasty band and sizing device
EP1779824A3 (en) Thermo-regulating patient support structure
BR0214805A (pt) Lama viscosa de alta perda de fluido solúvel em ácido para circulação perdida
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
DE60227676D1 (de) Verfahren und gerät für die externe herzstabilisierung
EA200100826A1 (ru) 16-галогенопроизводные эпотилона, способ их получения и их применение в фармацевтике
NO20015121D0 (no) Stigerör for forbindelse mellom et fartöy og et punkt på havbunnen
DE60204951D1 (de) Ccr5 antagonisten verwendbar für die behandlung von aids
DE60112705T2 (de) Blutsammelsatz
BR0200626A (pt) Agonistas beta3 e seus usos
CA2327635A1 (en) Uracil compounds and use thereof
RU2004100228A (ru) Замещенный арилазоимидазол для лечения недержания мочи при напряжении
DE50009938D1 (de) Verwendung von nanoskaligen wachsen
JP2000319116A5 (enExample)
DE60128346D1 (de) Elektrolytische lösung für elektrolytkondensator und diese verwendender elektrolytkondensator
JP2005500285A5 (enExample)
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ZA200405173B (en) 2&#39;-halo-3&#39;,5&#39;-dialkoxyphen-1&#39;yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence.
DE60203267D1 (de) Implantierbarer herzstimulator
EP1354928A3 (en) Liquid compositions for the treatment of metal surfaces
DE60017183D1 (de) Implantierbarer zweikammerherzstimmulator

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20060627